Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 488,643 |
|
|||||
| News | - | ||||||
| Day High | 12.96 | Low High |
|||||
| Day Low | 11.91 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Y mAbs Therapeutics Inc | YMAB | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.59 | -4.58% | 12.28 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 12.96 | 11.91 | 12.96 | 12.28 | 12.87 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,998 | 488,643 | $ 12.27 | $ 5,993,813 | - | 4.60 - 20.90 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:01:57 | priorref | 285 | $ 12.28 | USD |
Y mAbs Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 536.71M | 43.78M | - | 84.82M | -21.43M | -0.49 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Y mAbs Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical YMAB Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.50 | 17.7775 | 11.91 | 14.44 | 612,802 | -5.22 | -29.83% |
| 1 Month | 14.62 | 17.7775 | 11.91 | 15.00 | 409,176 | -2.34 | -16.01% |
| 3 Months | 16.00 | 20.90 | 11.91 | 15.67 | 371,911 | -3.72 | -23.25% |
| 6 Months | 5.11 | 20.90 | 4.69 | 12.67 | 353,013 | 7.17 | 140.31% |
| 1 Year | 9.98 | 20.90 | 4.60 | 10.36 | 289,441 | 2.30 | 23.05% |
| 3 Years | 34.93 | 39.8199 | 2.70 | 11.19 | 402,351 | -22.65 | -64.84% |
| 5 Years | 22.37 | 55.36 | 2.70 | 17.45 | 329,591 | -10.09 | -45.11% |
Y mAbs Therapeutics Description
| Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Its pipeline covers Naxitamab, Omburtamab, GD2-GD3 Vaccine, and others. |
